Michelle LeRoux Williams
Chief Tech/Sci/R&D Officer at ELUTIA INC.
Net worth: - $ as of 31/03/2024
Profile
Michelle LeRoux Williams is currently a member of the American Institute for Medical & Biological Engineering and the Chief Scientific Officer at Elutia, Inc. She was previously the Chief Scientific Officer at Osiris Therapeutics, Inc. from 2009 to 2014.
Dr. Williams holds a doctorate degree from Duke University and an undergraduate degree from Rice University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ELUTIA INC CLASS A
-.--% | 11/04/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Michelle LeRoux Williams active positions
| Companies | Position | Start |
|---|---|---|
| ELUTIA INC. | Chief Tech/Sci/R&D Officer | 26/08/2022 |
American Institute For Medical & Biological Engineering
 American Institute For Medical & Biological Engineering Miscellaneous Commercial ServicesCommercial Services American Institute For Medical & Biological Engineering engages in research and development of medical and biological engineering. The private company is based in Washington. | Corporate Officer/Principal | - |
Former positions of Michelle LeRoux Williams
| Companies | Position | End |
|---|---|---|
| OSIRIS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 15/04/2014 |
Training of Michelle LeRoux Williams
| Duke University | Doctorate Degree |
| Rice University | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Osiris Therapeutics, Inc.
 Osiris Therapeutics, Inc. BiotechnologyHealth Technology Osiris Therapeutics, Inc. engages in the research, development, manufacture, and commercialization of regenerative medicine products. Its biosurgery business focuses on using unique tissue preservation technologies to develop viable human tissue products designed to improve wound closure and surgical outcomes for patients and physicians over standard of care alone. The company was founded by Peter A. Friedli and James S. Burns on December 23, 1992 and is headquartered in Columbia, MD. | Health Technology |
American Institute For Medical & Biological Engineering
American Institute For Medical & Biological Engineering Miscellaneous Commercial ServicesCommercial Services American Institute For Medical & Biological Engineering engages in research and development of medical and biological engineering. The private company is based in Washington. | Commercial Services |
| Elutia, Inc. |
- Stock Market
- Insiders
- Michelle LeRoux Williams